Replies to post #145902 on NanoViricides Inc. (NNVC)

[loanranger]

Nobody knows what to expect.....
"NanoViricides GAAP EPS of -$0.17
Feb. 15, 2022 6:52 AM ETNanoViricides, Inc. (NNVC)By: Meghavi Singh, SA News Editor

NanoViricides press release (NYSE:NNVC): FQ2 GAAP EPS of -$0.17.
The Company reported that it had approximately $17.35M of cash, cash equivalents as of December 31, 2022.
The Company believes it has sufficient funds for initial human clinical trials of at least one of its drug candidates."

...including the Company itself.
>If we could only figure out which one of these things worked and on what, we could probably afford a trial for it.<